Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line
Authors
Keywords
-
Journal
MOLECULES
Volume 27, Issue 12, Pages 3661
Publisher
MDPI AG
Online
2022-06-13
DOI
10.3390/molecules27123661
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Targets of Triple-Negative Breast Cancer: Where Do We Stand?
- (2022) Emma E. Newton et al. Cancers
- Treatment Strategies Against Triple-Negative Breast Cancer: An Updated Review
- (2022) Mudasir Maqbool et al. Breast Cancer-Targets and Therapy
- Cyanidin-3-O-glucoside inhibits the β-catenin/MGMT pathway by upregulating miR-214-5p to reverse chemotherapy resistance in glioma cells
- (2022) Yuan Zhou et al. Scientific Reports
- Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence
- (2021) Bahare Salehi et al. Frontiers in Pharmacology
- Resveratrol Mediates the Apoptosis of Triple Negative Breast Cancer Cells by Reducing POLD1 Expression
- (2021) Zhi-Jie Liang et al. Frontiers in Oncology
- Resveratrol Enhances Inhibition Effects of Cisplatin on Cell Migration and Invasion and Tumor Growth in Breast Cancer MDA-MB-231 Cell Models In Vivo and In Vitro
- (2021) Meng-Die Yang et al. MOLECULES
- Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer
- (2021) Yu-Hsiang Huang et al. Scientific Reports
- Prognostic and Clinicopathologic Associations of LAG-3 Expression in Triple-negative Breast Cancer
- (2021) Elisabeth S. Stovgaard et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- α-Mangostin Induces Apoptosis and Inhibits Metastasis of Breast Cancer Cells via Regulating RXRα-AKT Signaling Pathway
- (2021) Xiuzhi Zhu et al. Frontiers in Pharmacology
- Triple Negative Breast Cancer: A Mountain Yet to Be Scaled Despite the Triumphs
- (2021) Qitong Wu et al. Cancers
- Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer
- (2021) Miquel Ensenyat-Mendez et al. Frontiers in Oncology
- Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies
- (2021) Jun Cao et al. Frontiers in Oncology
- Luteolin Inhibits Breast Cancer Stemness and Enhances Chemosensitivity through the Nrf2-Mediated Pathway
- (2021) Kuen-Jang Tsai et al. MOLECULES
- Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
- (2021) Ying Li et al. Frontiers in Oncology
- Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling
- (2020) Pradip Shahi Thakuri et al. BMC CANCER
- Berberine Impairs the Survival of Triple Negative Breast Cancer Cells: Cellular and Molecular Analyses
- (2020) Lamyae El Khalki et al. MOLECULES
- Effect of apigenin on whole transcriptome profile of TNFα‑activated MDA‑MB‑468 triple negative breast cancer cells
- (2020) David Bauer et al. Oncology Letters
- Phytochemicals as Potential Anticancer Drugs: Time to Ponder Nature’s Bounty
- (2020) Mohammad Arif Ashraf Biomed Research International
- EGFR Promotes the Development of Triple Negative Breast Cancer Through JAK/STAT3 Signaling
- (2020) Xiang Song et al. Cancer Management and Research
- Breast Tumor Microenvironment: Emerging target of therapeutic phytochemicals
- (2020) Rama Rao Malla et al. PHYTOMEDICINE
- The Landscape of Targeted Therapies in TNBC
- (2020) Elena Vagia et al. Cancers
- Curcumin inhibits the growth of triple‐negative breast cancer cells by silencing EZH2 and restoring DLC1 expression
- (2020) Xueliang Zhou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies
- (2020) Gagan K. Gupta et al. Cancers
- The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer
- (2020) Zimei Yang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Targeting the Wnt/β-catenin signaling pathway in cancer
- (2020) Ya Zhang et al. Journal of Hematology & Oncology
- Radiotherapy after surgery has significant survival benefits for patients with triple-negative breast cancer
- (2019) Yi Yao et al. Cancer Medicine
- A Natural Isoquinoline Alkaloid With Antitumor Activity: Studies of the Biological Activities of Berberine
- (2019) Da Liu et al. Frontiers in Pharmacology
- Targeting PI3K in cancer: mechanisms and advances in clinical trials
- (2019) Jing Yang et al. Molecular Cancer
- The Therapeutic Potential of Apigenin
- (2019) Bahare Salehi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Risk factors for distant Metastasis of patients with primary Triple Negative Breast Cancer
- (2019) Yi Yao et al. BIOSCIENCE REPORTS
- Molecular characterization of trophoblast cell surface antigen 2 (Trop-2) positive triple negative breast cancer (TNBC).
- (2019) Katia Khoury et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase Ib trial of the cyclin-dependent kinase inhibitor dinaciclib (dina) in combination with pembrolizumab (P) in patients with advanced triple-negative breast cancer (TNBC).
- (2019) Amy Jo Chien et al. JOURNAL OF CLINICAL ONCOLOGY
- STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
- (2019) Jiang-Jiang Qin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway
- (2019) Xiaohong Xu et al. BIOMEDICINE & PHARMACOTHERAPY
- Alpha-mangostin induces endoplasmic reticulum stress and autophagy which count against fatty acid synthase inhibition mediated apoptosis in human breast cancer cells
- (2019) Wenyuan Huang et al. Cancer Cell International
- Ampelopsin E Reduces the Invasiveness of the Triple Negative Breast Cancer Cell Line, MDA-MB-231
- (2019) Francis Yew Fu Tieng et al. MOLECULES
- Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
- (2019) Park et al. Cancers
- Endocrine and Targeted Therapy for Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer: Insights to Sequencing Treatment and Overcoming Resistance Based on Clinical Trials
- (2019) Rola El Sayed et al. Frontiers in Oncology
- A Sesquiterpenoid from Farfarae Flos Induces Apoptosis of MDA-MB-231 Human Breast Cancer Cells through Inhibition of JAK–STAT3 Signaling
- (2019) Hyeri Jang et al. Biomolecules
- Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling
- (2019) Yan Chen et al. BIOCHEMICAL PHARMACOLOGY
- Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
- (2019) Jichao He et al. BREAST CANCER RESEARCH AND TREATMENT
- Recent nanotechnological interventions targeting PI3K/Akt/mTOR pathway: A focus on breast cancer
- (2019) VarRuchi Sharma et al. SEMINARS IN CANCER BIOLOGY
- Epidermal growth factor receptor (EGFR) gene alteration and protein overexpression in Malaysian triple-negative breast cancer (TNBC) cohort
- (2019) Zubaidah Zakaria et al. OncoTargets and Therapy
- Eupalinolide J Suppresses the Growth of Triple-Negative Breast Cancer Cells via Targeting STAT3 Signaling Pathway
- (2019) Chenghua Lou et al. Frontiers in Pharmacology
- Antitumor Activity of Vanicoside B Isolated from Persicaria dissitiflora by Targeting CDK8 in Triple-Negative Breast Cancer Cells
- (2019) Donghwa Kim et al. JOURNAL OF NATURAL PRODUCTS
- Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
- (2019) Shuang Qin et al. Molecular Cancer
- An increased cell cycle gene network determines MEK and Akt inhibitor double resistance in triple-negative breast cancer
- (2019) Vera E. van der Noord et al. Scientific Reports
- The Modulatory Properties of Astragalus membranaceus Treatment on Triple-Negative Breast Cancer: An Integrated Pharmacological Method
- (2019) Cun Liu et al. Frontiers in Pharmacology
- Molecular Mechanisms of Action of Genistein in Cancer: Recent Advances
- (2019) Hardeep Singh Tuli et al. Frontiers in Pharmacology
- Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents
- (2018) Matteo Santoni et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Schisandrin A prevents oxidative stress-induced DNA damage and apoptosis by attenuating ROS generation in C2C12 cells
- (2018) Yung Hyun Choi BIOMEDICINE & PHARMACOTHERAPY
- Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer
- (2018) Jia Jin et al. BMC CANCER
- Targeting FGFR pathway in breast cancer
- (2018) J. Perez-Garcia et al. BREAST
- Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
- (2018) Ricardo L. B. Costa et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer
- (2018) Aditya Bardia et al. BREAST CANCER RESEARCH AND TREATMENT
- Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
- (2018) Frederick Arce Vargas et al. CANCER CELL
- The role of STAT3 in leading the crosstalk between human cancers and the immune system
- (2018) Yu Wang et al. CANCER LETTERS
- Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
- (2018) L. Gerratana et al. CANCER TREATMENT REVIEWS
- Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
- (2018) Charissa Kim et al. CELL
- Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer
- (2018) Patrick G. Morris et al. Clinical Breast Cancer
- Annona muricata Leaf Extract Triggered Intrinsic Apoptotic Pathway to Attenuate Cancerous Features of Triple Negative Breast Cancer MDA-MB-231 Cells
- (2018) Jee Young Kim et al. Evidence-based Complementary and Alternative Medicine
- Effects of α-Mangostin on Viability, Growth and Cohesion of Multicellular Spheroids Derived from Human Breast Cancer Cell Lines
- (2018) Giuseppe Scolamiero et al. International Journal of Medical Sciences
- Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer
- (2018) Abhishek Gangrade et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer
- (2018) Tiffany A. Traina et al. JOURNAL OF CLINICAL ONCOLOGY
- A novel anti-triple negative breast cancer compound isolated from medicinal herb Myrothamnus flabellifolius
- (2018) Brar Jaspal et al. Journal of Medicinal Plants Research
- (−)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer
- (2018) Joan Crous-Masó et al. MOLECULES
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- F1012-2 inhibits the growth of triple negative breast cancer through induction of cell cycle arrest, apoptosis, and autophagy
- (2018) Shasha Tian et al. PHYTOTHERAPY RESEARCH
- Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features
- (2018) Kristine Astvatsaturyan et al. PLoS One
- Cantharidin suppresses cell growth and migration, and activates autophagy in human non-small cell lung cancer cells
- (2018) Yan‑Peng Liu et al. Oncology Letters
- The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target
- (2018) David M. Goldenberg et al. Oncotarget
- Metastatic and triple-negative breast cancer: challenges and treatment options
- (2018) Sumayah Al-Mahmood et al. Drug Delivery and Translational Research
- Simvastatin functions as a heat shock protein 90 inhibitor against triple-negative breast cancer
- (2018) Xinhui Kou et al. CANCER SCIENCE
- Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal Pathway
- (2018) Jie Li et al. Frontiers in Pharmacology
- The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
- (2018) Elizabeth Varghese et al. Cancers
- 301PAnalysis of the JAK2 gene in triple-negative breast cancer (TNBC)
- (2018) L Stanek et al. ANNALS OF ONCOLOGY
- Anticancer Activity of Natural Compounds from Plant and Marine Environment
- (2018) Anna Lichota et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Aurantoside C Targets and Induces Apoptosis in Triple Negative Breast Cancer Cells
- (2018) Sumi Shrestha et al. Marine Drugs
- A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy
- (2018) Wenda Zhang et al. Cell Death & Disease
- Ganoderma lucidum extract (GLE) impairs breast cancer stem cells by targeting the STAT3 pathway
- (2018) Tiffany J. Rios-Fuller et al. Oncotarget
- The clinical promise of immunotherapy in triple-negative breast cancer
- (2018) Praveen Vikas et al. Cancer Management and Research
- The selective effect of glycyrrhizin and glycyrrhetinic acid on topoisomerase IIα and apoptosis in combination with etoposide on triple negative breast cancer MDA-MB-231 cells
- (2017) Yun Cai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Structure–Activity Relationships of New Natural Product-Based Diaryloxazoles with Selective Activity against Androgen Receptor-Positive Breast Cancer Cells
- (2017) Andrew J. Robles et al. JOURNAL OF MEDICINAL CHEMISTRY
- Quercetin induces apoptosis and cell cycle arrest in triple-negative breast cancer cells through modulation of Foxo3a activity
- (2017) Lich Thi Nguyen et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Research Progress in the Modification of Quercetin Leading to Anticancer Agents
- (2017) Alessandro Massi et al. MOLECULES
- Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells
- (2017) Hyo Joo Byun et al. ONCOLOGY REPORTS
- Glycyrrhizic acid induces human MDA-MB-231 breast cancer cell death and autophagy via the ROS-mitochondrial pathway
- (2017) Shu-Chuan Lin et al. ONCOLOGY REPORTS
- Triple-negative breast cancer and the potential for targeted therapy
- (2017) Jing-Ru Jhan et al. PHARMACOGENOMICS
- Potential Anti-inflammatory Sesquiterpene Lactones from Eupatorium lindleyanum
- (2017) Fang Wang et al. PLANTA MEDICA
- Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics
- (2017) Angelo Gámez-Pozo et al. PLoS One
- The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer
- (2017) Iram Fatima et al. PLoS One
- Epigallocatechin gallate inhibits the growth of MDA-MB-231 breast cancer cells via inactivation of the β-catenin signaling pathway
- (2017) On-Yu Hong et al. Oncology Letters
- Combined targeting of Raf and Mek synergistically inhibits tumorigenesis in triple negative breast cancer model systems
- (2017) Teddy S. Nagaria et al. Oncotarget
- Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agent
- (2017) Bernadette V. Marquez-Nostra et al. Oncotarget
- [10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer in vivo
- (2017) Ana Carolina B.M. Martin et al. Oncotarget
- AR Signaling in Breast Cancer
- (2017) Bilal Rahim et al. Cancers
- Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer
- (2017) Yuka Asano et al. Cancers
- Strategies and Approaches of Targeting STAT3 for Cancer Treatment
- (2016) Steffanie L. Furtek et al. ACS Chemical Biology
- Astragalus membranaceus: A Review of its Protection Against Inflammation and Gastrointestinal Cancers
- (2016) Kathy K. Auyeung et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- CTLA-4 and PD-1 Pathways
- (2016) Elizabeth I. Buchbinder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition
- (2016) Shweta Shrivastava et al. BIOFACTORS
- Abstract LB-216: NCI 9455: Phase II study of trametinib followed by trametinib plus AKT inhibitor,GSK2141795 in patients with advanced triple negative breast cancer
- (2016) Bhuvaneswari Ramaswamy et al. CANCER RESEARCH
- Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast Cancer
- (2016) Vanessa F. Merino et al. CANCER RESEARCH
- Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells
- (2016) Francesco Caiazza et al. ENDOCRINE-RELATED CANCER
- Androgen receptor signaling pathways as a target for breast cancer treatment
- (2016) Elisabetta Pietri et al. ENDOCRINE-RELATED CANCER
- Quantitative phosphoproteomics reveals genistein as a modulator of cell cycle and DNA damage response pathways in triple-negative breast cancer cells
- (2016) YI FANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Molecular Classification of Triple-Negative Breast Cancer
- (2016) Sung Gwe Ahn et al. Journal of Breast Cancer
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression
- (2016) Dan Lin et al. ONCOLOGY REPORTS
- Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence
- (2016) Justin M. Balko et al. Science Translational Medicine
- Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer
- (2016) Domenico Ribatti et al. Translational Oncology
- α-Mangostin from Garcinia mangostana Linn: An updated review of its pharmacological properties
- (2016) Mohamed Yousif Ibrahim et al. Arabian Journal of Chemistry
- Cyanidin-3-o-glucoside directly binds to ERα36 and inhibits EGFR-positive triple-negative breast cancer
- (2016) Li Wang et al. Oncotarget
- Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers
- (2016) Pradip De et al. Oncotarget
- Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer
- (2016) Abderrahim El Guerrab et al. Oncotarget
- Genomic regulation of invasion by STAT3 in triple negative breast cancer
- (2016) Joy M. McDaniel et al. Oncotarget
- The hedgehog pathway in triple-negative breast cancer
- (2016) Joyce G. Habib et al. Cancer Medicine
- Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
- (2016) Brian D. Lehmann et al. PLoS One
- PARP inhibitors in the management of breast cancer: current data and future prospects
- (2015) Luca Livraghi et al. BMC Medicine
- Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin
- (2015) Masaya Kai et al. BREAST CANCER RESEARCH AND TREATMENT
- Piperine inhibits the growth and motility of triple-negative breast cancer cells
- (2015) Anna L. Greenshields et al. CANCER LETTERS
- Abstract 4233: Wnt pathway antagonist ipafricept (FZD8-Fc, OMP-54F28) inhibits tumor growth and reduces tumor-initiating cell frequency in ovarian patient-derived xenograft models
- (2015) Marcus M. Fischer et al. CANCER RESEARCH
- Wnt/ -Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells
- (2015) G.-B. Jang et al. CANCER RESEARCH
- Cooperatively transcriptional and epigenetic regulation of sonic hedgehog overexpression drives malignant potential of breast cancer
- (2015) Zhao-Heng Duan et al. CANCER SCIENCE
- First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors
- (2015) A. N. Starodub et al. CLINICAL CANCER RESEARCH
- Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2-SN-38 Antibody Conjugate (Sacituzumab Govitecan)
- (2015) R. M. Sharkey et al. CLINICAL CANCER RESEARCH
- Targeting the androgen receptor in prostate and breast cancer: several new agents in development
- (2015) T. Proverbs-Singh et al. ENDOCRINE-RELATED CANCER
- Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt
- (2015) Abeer Bahnassy et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer
- (2015) Zahi Mitri et al. INVESTIGATIONAL NEW DRUGS
- Influence of Androgen Receptor Expression on the Survival Outcomes in Breast Cancer: A Meta-Analysis
- (2015) Yoonseok Kim et al. Journal of Breast Cancer
- EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer
- (2015) Denise A. Yardley et al. JOURNAL OF CLINICAL ONCOLOGY
- Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer
- (2015) Fergus J. Couch et al. JOURNAL OF CLINICAL ONCOLOGY
- Olaparib Monotherapy in Patients With Advanced Cancer and a GermlineBRCA1/2Mutation
- (2015) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectives
- (2015) Ning Wang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo
- (2015) V. N. Barton et al. MOLECULAR CANCER THERAPEUTICS
- Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells
- (2015) A. Schech et al. MOLECULAR CANCER THERAPEUTICS
- Quercetin regulates β-catenin signaling and reduces the migration of triple negative breast cancer
- (2015) Asha Srinivasan et al. MOLECULAR CARCINOGENESIS
- Targeting Notch, Hedgehog and Wnt pathways in cancer stem cells: clinical update
- (2015) Naoko Takebe et al. Nature Reviews Clinical Oncology
- IM-412 inhibits the invasion of human breast carcinoma cells by blocking FGFR-mediated signaling
- (2015) SEUNG-YOUN JUNG et al. ONCOLOGY REPORTS
- 10-Gingerol inhibits proliferation and invasion of MDA-MB-231 breast cancer cells through suppression of Akt and p38MAPK activity
- (2015) JI-HYE JOO et al. ONCOLOGY REPORTS
- Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)*
- (2015) David M. Goldenberg et al. Oncotarget
- Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer
- (2015) Michael T. Barrett et al. Oncotarget
- Mutant p53: Multiple Mechanisms Define Biologic Activity in Cancer
- (2015) Michael Paul Kim et al. Frontiers in Oncology
- Triple Negative Breast Cancer
- (2014) Idil Cetin et al. Asian Pacific Journal of Cancer Prevention
- Green tea polyphenol EGCG suppresses Wnt/β-catenin signaling by promoting GSK-3β- and PP2A-independent β-catenin phosphorylation/degradation
- (2014) Sangtaek Oh et al. BIOFACTORS
- A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer
- (2014) Komal Jhaveri et al. Clinical Breast Cancer
- Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Locally Advanced or Metastatic Breast Cancer
- (2014) Johanna Bendell et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmaceutical properties of calycosin, the major bioactive isoflavonoid in the dry root extract ofRadix astragali
- (2014) JunQing Gao et al. PHARMACEUTICAL BIOLOGY
- Naturally occurring chalcones and their biological activities
- (2014) Zsuzsanna Rozmer et al. PHYTOCHEMISTRY REVIEWS
- PD-L1 Expression Is Increased in a Subset of Basal Type Breast Cancer Cells
- (2014) Hatem Soliman et al. PLoS One
- Cucurbitacin E Induces Cell Cycle G2/M Phase Arrest and Apoptosis in Triple Negative Breast Cancer
- (2014) Yanjie Kong et al. PLoS One
- The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
- (2014) Elisavet Paplomata et al. Therapeutic Advances in Medical Oncology
- Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
- (2014) Ailian Xiong et al. Cancers
- Breast Cancer Metastasis
- (2013) Natascia Marino et al. AMERICAN JOURNAL OF PATHOLOGY
- Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors
- (2013) R. Dienstmann et al. ANNALS OF ONCOLOGY
- Histone deacetylase inhibitors
- (2013) Marije Slingerland et al. ANTI-CANCER DRUGS
- Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer
- (2013) Giuseppe Curigliano et al. BREAST
- Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
- (2013) H. Masuda et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
- (2013) A. Gucalp et al. CLINICAL CANCER RESEARCH
- Triple-negative breast cancer
- (2013) Kim M. Hirshfield et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation
- (2013) Hira Lal Goel et al. EMBO Molecular Medicine
- The Management of Early-Stage and Metastatic Triple-Negative Breast Cancer
- (2013) Carey K. Anders et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
- (2013) Brian D Lehmann et al. JOURNAL OF PATHOLOGY
- Piper nigrumand Piperine: An Update
- (2013) Murlidhar Meghwal et al. PHYTOTHERAPY RESEARCH
- Expression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer
- (2013) R. Joseph Bender et al. PLoS One
- Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
- (2013) J. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway
- (2013) Hongzhong Li et al. TOXICOLOGY LETTERS
- Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
- (2013) M. J. Selby et al. Cancer Immunology Research
- Expression of androgen receptors in triple negative breast carcinomas
- (2012) Ivana Mrklić et al. ACTA HISTOCHEMICA
- Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents
- (2012) F. Andre et al. ANNALS OF ONCOLOGY
- Fisetin: A Dietary Antioxidant for Health Promotion
- (2012) Naghma Khan et al. ANTIOXIDANTS & REDOX SIGNALING
- Role of epidermal growth factor receptor in breast cancer
- (2012) Hiroko Masuda et al. BREAST CANCER RESEARCH AND TREATMENT
- Role of PARP Inhibitors in Cancer Biology and Therapy
- (2012) D. Davar et al. CURRENT MEDICINAL CHEMISTRY
- Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway
- (2012) HONG PAN et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Dissecting the Heterogeneity of Triple-Negative Breast Cancer
- (2012) Otto Metzger-Filho et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigallocatechin gallate induce cell death and apoptosis in triple negative breast cancer cells Hs578T
- (2012) Cornelia Braicu et al. JOURNAL OF DRUG TARGETING
- Curcumin induces apoptosis of triple-negative breast cancer cells by inhibition of EGFR expression
- (2012) XIAO-DONG SUN et al. Molecular Medicine Reports
- HDAC inhibitor-based therapies: Can we interpret the code?
- (2012) Maria New et al. Molecular Oncology
- Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
- (2012) A. Gurney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Heat shock protein 90 inhibition: rationale and clinical potential
- (2012) Robert B. Den et al. Therapeutic Advances in Medical Oncology
- FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both In Vitro and In Vivo
- (2011) Rachel Sharpe et al. CLINICAL CANCER RESEARCH
- Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women
- (2011) R. Hu et al. CLINICAL CANCER RESEARCH
- The Emerging Role of Poly(ADP-Ribose) Polymerase Inhibitors in Cancer Treatment
- (2011) Shahneen K. Sandhu et al. CURRENT DRUG TARGETS
- Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray
- (2011) Jiehua He et al. MEDICAL ONCOLOGY
- Antioxidant Activities of Extracts and Fractions from Eupatorium lindleyanum DC
- (2011) Guilong Yan et al. MOLECULES
- Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61
- (2011) L G Harris et al. ONCOGENE
- The Role of Nutraceuticals in Chemoprevention and Chemotherapy and Their Clinical Outcomes
- (2011) Sabita N. Saldanha et al. Journal of Oncology
- Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes
- (2010) Mothaffar F. Rimawi et al. CANCER
- Secondary mutations of BRCA1/2 and drug resistance
- (2010) Kiranjit K. Dhillon et al. CANCER SCIENCE
- Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer
- (2009) B. K. Linderholm et al. ANNALS OF ONCOLOGY
- Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models
- (2009) E. Caldas-Lopes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
- (2008) Yong Lin et al. CURRENT CANCER DRUG TARGETS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search